OAS1 and COVID-19: Although these participants were recruited at different times after recovery, we were able to show a consistent result for MTB-stimulated IFN-γ SPUs as well as gene expression levels of OAS1, MAVS and SOCS3 between COVID-19 sub-groups in comparison with controls.